We are live on
!
Find out more
GCM
Goldstream Capital Management Portfolio holdings
AUM
$120M
1-Year Est. Return
122.01%
This Fund
S&P 500
This Quarter
Est. Return
-38.38%
1 Year Est. Return
+122.01%
3 Year Est. Return
+403.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$283M
(-71%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-136.07%
Top 10 Holdings %
Top 10 Hldgs %
99.99%
Holding
18
New
3
Increased
–
Reduced
5
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.31M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$577K |
| 3 |
Intellia Therapeutics
NTLA
|
+$203K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$131M |
| 2 |
NVIDIA
NVDA
|
+$13.5M |
| 3 |
Strategy Inc
MSTR
|
+$6.94M |
| 4 |
Apple
AAPL
|
+$2.42M |
| 5 |
Microsoft
MSFT
|
+$2.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 82.06% |
| 2 | Technology | 14.57% |
| 3 | Healthcare | 0.57% |
| 4 | Financials | 0.41% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.24T
| $94.1M | 82.06% |
419,400
-479,100
| -53% | -$131M |
|
|
2
NVIDIA
NVDA
$5.01T
| $10.6M | 9.25% |
700,000
-716,290
| -51% | -$13.5M |
|
|
3
Strategy Inc
MSTR
$33.5B
| $3.78M | 3.29% |
230,000
-240,000
| -51% | -$6.94M |
|
|
4
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $2.29M | 1.99% |
+30,800
| New | +$2.31M |
|
|
5
Microsoft
MSFT
$2.84T
| $2.06M | 1.79% |
8,000
-7,500
| -48% | -$2.04M |
|
6
Coinbase
COIN
$41.7B
| $470K | 0.41% |
10,000
| – | – |
|
|
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $443K | 0.39% |
+46,000
| New | +$577K |
|
8
Invesco QQQ Trust
QQQ
$455B
| $441K | 0.38% |
1,572
| – | – |
|
|
9
Apple
AAPL
$4.89T
| $273K | 0.24% |
2,000
-16,000
| -89% | -$2.42M |
|
|
10
Intellia Therapeutics
NTLA
$1.5B
| $207K | 0.18% |
+4,000
| New | +$203K |
|
11
iShares Biotechnology ETF
IBB
$9.31B
| $14K | 0.01% |
123
| – | – |
|
12
CF Industries
CF
$19.2B
| – | – |
-486
| Closed | -$50K |
|
13
SPDR Gold Trust
GLD
$131B
| – | – |
-1,295
| Closed | -$234K |
|
14
Alphabet (Google) Class C
GOOG
$3.9T
| – | – |
-4,000
| Closed | -$559K |
|
15
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| – | – |
-3,000
| Closed | -$1.36M |
|
16
TSMC
TSM
$2.09T
| – | – |
-5,900
| Closed | -$617K |
|
17
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| – | – |
-10,000
| Closed | -$382K |
|
18
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
| – | – |
-5,110
| Closed | -$313K |
|
Similar funds
GSM
WPA
BIS
DWA
PA
TGM
AAA
SCVTA
Goldstream Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Goldstream Capital Management held 18 positions worth $115M, down 71% from $398M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Goldstream Capital Management withdrew a net $156M in Q2 2022, closing 7 positions and reducing 5 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $1.36M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 82% of assets, up from 81% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldstream Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $2.29M.
- Goldstream Capital Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 30,800 shares worth $2.29M.
- Goldstream Capital Management's biggest Q2 2022 reduction was Tesla, cutting an estimated $131M.
- Goldstream Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $1.36M.
- Goldstream Capital Management's ten largest holdings make up 100% of its $115M portfolio in Q2 2022.
- Goldstream Capital Management opened 3 new positions and closed 7 in Q2 2022.
- Goldstream Capital Management's portfolio value fell 71% quarter-over-quarter to $115M.
Based on Goldstream Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.